These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 38849770)
1. Prediction of the axillary lymph-node metastatic burden of breast cancer by Li Y; Han D; Shen C BMC Cancer; 2024 Jun; 24(1):704. PubMed ID: 38849770 [TBL] [Abstract][Full Text] [Related]
2. Construction of a comprehensive predictive model for axillary lymph node metastasis in breast cancer: a retrospective study. Li Y; Han D; Shen C; Duan X BMC Cancer; 2023 Oct; 23(1):1028. PubMed ID: 37875818 [TBL] [Abstract][Full Text] [Related]
4. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study. Eifer M; Pinian H; Klang E; Alhoubani Y; Kanana N; Tau N; Davidson T; Konen E; Catalano OA; Eshet Y; Domachevsky L Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985 [TBL] [Abstract][Full Text] [Related]
5. The role of ultrasonography and FDG-PET in axillary lymph node staging of breast cancer. Ahn JH; Son EJ; Kim JA; Youk JH; Kim EK; Kwak JY; Ryu YH; Jeong J Acta Radiol; 2010 Oct; 51(8):859-65. PubMed ID: 20670083 [TBL] [Abstract][Full Text] [Related]
6. Preoperative prediction of lymph node metastasis in colorectal cancer using Wang Y; Zhao H; Fu P; Tian L; Su Y; Lyu Z; Gu W; Wang Y; Liu S; Wang X; Zheng H; Du J; Zhang R Med Phys; 2024 Aug; 51(8):5214-5225. PubMed ID: 38801340 [TBL] [Abstract][Full Text] [Related]
7. PET/CT in breast cancer staging is useful for evaluation of axillary lymph node and distant metastases. Davidson T; Shehade N; Nissan E; Sklair-Levy M; Ben-Haim S; Barshack I; Zippel D; Halevy A; Chikman B Surg Oncol; 2021 Sep; 38():101567. PubMed ID: 33866190 [TBL] [Abstract][Full Text] [Related]
8. Machine Learning Model for Predicting Axillary Lymph Node Metastasis in Clinically Node Positive Breast Cancer Based on Peritumoral Ultrasound Radiomics and SHAP Feature Analysis. Wang SR; Cao CL; Du TT; Wang JL; Li J; Li WX; Chen M J Ultrasound Med; 2024 Sep; 43(9):1611-1625. PubMed ID: 38808580 [TBL] [Abstract][Full Text] [Related]
9. Discordant results in Parisse-Di Martino S; Faure C; Mognetti T Cancer Treat Res Commun; 2021; 27():100344. PubMed ID: 33636590 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the diagnostic value of FDG-PET/CT and axillary ultrasound for the detection of lymph node metastases in breast cancer patients. Riegger C; Koeninger A; Hartung V; Otterbach F; Kimmig R; Forsting M; Bockisch A; Antoch G; Heusner TA Acta Radiol; 2012 Dec; 53(10):1092-8. PubMed ID: 23002144 [TBL] [Abstract][Full Text] [Related]
11. Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management. Greco M; Crippa F; Agresti R; Seregni E; Gerali A; Giovanazzi R; Micheli A; Asero S; Ferraris C; Gennaro M; Bombardieri E; Cascinelli N J Natl Cancer Inst; 2001 Apr; 93(8):630-5. PubMed ID: 11309439 [TBL] [Abstract][Full Text] [Related]
12. 2-[ Xu L; Huang G; Wang Y; Huang G; Liu J; Chen R Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1729-1740. PubMed ID: 38150017 [TBL] [Abstract][Full Text] [Related]
13. Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer. Fujii T; Yajima R; Tatsuki H; Kuwano H Anticancer Res; 2016 Apr; 36(4):1785-9. PubMed ID: 27069160 [TBL] [Abstract][Full Text] [Related]
14. Deep-learning features based on F18 fluorodeoxyglucose positron emission tomography/computed tomography ( Wang H; Zhang J; Li Y; Wang D; Zhang T; Yang F; Li Y; Zhang Y; Yang L; Li P Clin Radiol; 2024 Sep; 79(9):e1152-e1158. PubMed ID: 38955636 [TBL] [Abstract][Full Text] [Related]
15. A prospective comparative study of ultrasonography, contrast-enhanced MRI and 18F-FDG PET/CT for preoperative detection of axillary lymph node metastasis in breast cancer patients. Guney IB; Dalci K; Teke ZT; Kucuker KA Ann Ital Chir; 2020; 91():458-464. PubMed ID: 32213685 [TBL] [Abstract][Full Text] [Related]
16. Identification of Axillary Lymph Node Metastasis in Patients With Breast Cancer Using Dual-Phase FDG PET/CT. Sasada S; Masumoto N; Kimura Y; Kajitani K; Emi A; Kadoya T; Okada M AJR Am J Roentgenol; 2019 Nov; 213(5):1129-1135. PubMed ID: 31339353 [No Abstract] [Full Text] [Related]
17. Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study. van Nijnatten TJA; Goorts B; Vöö S; de Boer M; Kooreman LFS; Heuts EM; Wildberger JE; Mottaghy FM; Lobbes MBI; Smidt ML Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):179-186. PubMed ID: 28905091 [TBL] [Abstract][Full Text] [Related]
18. The new perspective of PET/CT for axillary nodal staging in early breast cancer patients according to ACOSOG Z0011 trial PET/CT axillary staging according to Z0011. Kong E; Choi J Nucl Med Commun; 2021 Dec; 42(12):1369-1374. PubMed ID: 34392296 [TBL] [Abstract][Full Text] [Related]
19. Radiomics in cone-beam breast CT for the prediction of axillary lymph node metastasis in breast cancer: a multi-center multi-device study. Zhu Y; Ma Y; Zhai Z; Liu A; Wang Y; Zhang Y; Li H; Zhao M; Han P; Yin L; He N; Wu Y; Sechopoulos I; Ye Z; Caballo M Eur Radiol; 2024 Apr; 34(4):2576-2589. PubMed ID: 37782338 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of (18)F-FDG PET/CT for axillary lymph node staging in patients with breast cancer. Kitajima K; Fukushima K; Miyoshi Y; Katsuura T; Igarashi Y; Kawanaka Y; Mouri M; Maruyama K; Yamano T; Doi H; Yamakado K; Hirota S; Hirota S Jpn J Radiol; 2016 Mar; 34(3):220-8. PubMed ID: 26715510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]